Corina Oprea Selected Research

coltuximab ravtansine

1/2018	A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.
3/2016	A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Corina Oprea Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 04/2002
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 03/2016
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Multiple Myeloma 12/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018
1	Disease Progression 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 03/2015
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Hepatocellular Carcinoma (Hepatoma) 01/2006
1	Fibrosis (Cirrhosis) 01/2006
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2002
1	Leukemia 05/2002
1	Lymphoma (Lymphomas) 05/2002
1	Second Primary Neoplasms (Neoplasms, Second) 05/2002
1	Neutropenia 04/2002
1	Fever of Unknown Origin 04/2002
1	Aspergillosis 04/2002
1	Infections 04/2002

Drug/Important Bio-Agent (IBA)

4	Docetaxel (Taxotere)FDA Link 03/2015 - 01/2006
2	isatuximabIBA 01/2022 - 12/2020
2	coltuximab ravtansineIBA 01/2018 - 03/2016
1	Thomsen-Friedenreich antibodiesIBA 01/2022
1	Monoclonal AntibodiesIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	AntibodiesIBA 01/2020
1	AntigensIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	taxaneIBA 03/2015
1	cabazitaxel FDA Link 03/2015
1	Hormones (Hormone)IBA 03/2015
1	Carboplatin (JM8)FDA LinkGeneric 12/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2014
1	AC 7700IBA 12/2014
1	Cisplatin (Platino)FDA LinkGeneric 12/2014
1	Capecitabine (Xeloda)FDA Link 01/2011
1	Epirubicin (Ellence)FDA LinkGeneric 01/2011
1	ImmunosorbentsIBA 04/2002
1	galactomannanIBA 04/2002
1	EnzymesIBA 04/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 05/2002
4	Drug Therapy (Chemotherapy) 01/2022 - 05/2002
3	Immunotherapy 01/2022 - 01/2018
1	Castration 03/2015
1	Intravenous Infusions 03/2015
1	Hematopoietic Stem Cell Transplantation 04/2002